| Literature DB >> 28562831 |
Marcelo S Nacif1,2,3, Andre L C Almeida2, Alistair A Young4, Brett R Cowan4, Anderson C Armstrong2, Eunice Yang1, Christopher T Sibley1, W Gregory Hundley5, Songtao Liu1, Joao Ac Lima2, David A Bluemke1,6.
Abstract
BACKGROUND: : Cardiac Magnetic Resonance is in need of a simple and robust method for diastolic function assessment that can be done with routine protocol sequences.Entities:
Mesh:
Year: 2017 PMID: 28562831 PMCID: PMC5489326 DOI: 10.5935/abc.20170063
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Figure 1Flowchart of the study population. Abbreviation: CMR: cardiac magnetic resonance.
Figure 2Screenshots of different diastolic function examples using the program CIM. A) Normal, B) impaired, and C) reduced. The following measurements were assessed: end-systole (ES), end-diastole (ED), early peak filling rate (E), atrial peak filling rate (A), and deceleration time (DT). All timing measurements were defined semiautomatically with manual correction with the observer using a slider on the time/rate curve.
Figure 3Three-dimensional displays of the model fits throughout the cardiac cycle in one R-R interval of 870 ms (outside images) for volume- and derivative-curve assessment (mL/s). Septal and lateral guide points motion can be evaluated through time, calculating the distance between the defined point and the model apex for myocardial longitudinal relaxation rate (mm/s). The endocardial surface is shaded in red and drawn with green lines.
Population characteristics by diastolic function grades
| Normal n = 66 (64.70%) | Type I n = 21 (20.60%) | Type II n = 15 (14.70%) | p value | |
|---|---|---|---|---|
| Age (years) | 66.8 ± 8.9 | 65.5 ± 7.5 | 64.4 ± 9.7 | 0.60 |
| 45 to 64 years | 24 (36.3) | 11 (52.3) | 7 (46.6) | 0.48 |
| 65 to 84 years | 42 (63.6) | 10 (47.6) | 8 (53.3) | 0.48 |
| Gender (male) | 26 (39.3) | 7 (33.3) | 6 (40.0) | 0.91 |
| White, Caucasian | 41 (62.0) | 11 (55.0) | 6 (40.0) | 0.25 |
| Black, African-American | 25 (38.0) | 10 (45.0) | 9 (60.0) | 0.25 |
| Weight (kg) | 77.5 ± 15.1 | 80.3 ± 19.4 | 80.3 ± 22.2 | 0.73 |
| Height (cm) | 168.0 ± 9.4 | 166.0 ± 11.2 | 166.1 ± 9.7 | 0.65 |
| BMI (kg/m2) | 28.0 ± 4.4 | 29.1 ± 5.7 | 28.2 ± 7.1 | 0.71 |
| BSA | 1.8 ± 0.2 | 1.8 ± 0.2 | 1.8 ± 0.2 | 0.89 |
| Never | 27 (40.9) | 9 (42.8) | 5 (33.3) | 0.37 |
| Former | 33 (50.0) | 12 (57.1) | 7 (46.6) | 0.37 |
| Current | 6 (9.0) | 0 (0.0) | 3 (20.0) | 0.37 |
| Systolic blood pressure (mmHg) | 121.8 ± 18.7 | 119.8 ± 14.6 | 121.3 ± 25.9 | 0.91 |
| Diastolic blood pressure (mmHg) | 71.2 ± 11.2 | 66.3 ± 10.6 | 69.1 ± 10.7 | 0.21 |
| Hypertension (%) | 33 (50.0) | 7 (33.3) | 9 (60.0) | 0.28 |
| Any hypertension medication | 31 (46.9) | 6 (28.5) | 9 (60.0) | 0.20 |
| Diabetes (%) | 3 (4.5) | 2 (9.5) | 3 (20.0) | 0.11 |
| Triglycerides (mg/dL) | 111.9 ± 60.5 | 100.3 ± 67.3 | 101.3 ± 54.8 | 0.68 |
| LDL cholesterol (mg/dL) | 111.5 ± 32.3 | 109.1 ± 34.2 | 112.4 ± 42.9 | 0.95 |
| HDL cholesterol (mg/dL) | 58.9 ± 18.4 | 62.4 ± 24.9 | 52.6 ± 12.0 | 0.33 |
| Total cholesterol (mg/dL) | 192.8 ± 38.5 | 191.5 ± 38.8 | 185.2 ± 52.7 | 0.81 |
| Metabolic syndrome | 21 (31.8) | 4 (19.0) | 2 (13.0) | 0.26 |
| Heart rate (beats/min) | 64.8 ± 9.6 | 65.0 ± 9.4 | 62.6 ± 5.7 | 0.66 |
| End-diastolic diameter (mm) | 4.4 ± 0.5 | 4.5 ± 0.5 | 4.6 ± 0.4 | 0.44 |
| Diastolic septal thickness (mm) | 1.0 ± 0.2 | 1.0 ± 0.1 | 0.9 ± 0.1 | 0.18 |
| Diastolic inferolateral thickness (mm) | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.66 |
| Heart rate (beats/min) | 65.2 ± 10.4 | 66.4 ± 9.7 | 61.6 ± 5.5 | 0.31 |
| Ejection fraction (%) | 69.0 ± 7.3 | 70.7 ± 7.0 | 70.6 ± 10.2 | 0.51 |
| End-diastolic volume (mL) | 106.8 ± 24.4 | 110.6 ± 28.7 | 99.6 ± 22.1 | 0.43 |
| End-systolic volume (mL) | 33.8 ± 13.6 | 33.5 ± 14.2 | 28.8 ± 10.6 | 0.42 |
| LV mass (g) | 124.8 ± 34.4 | 132.5 ± 38.2 | 121.8 ± 26.2 | 0.59 |
| Stroke volume (mL) | 73.0 ± 15.1 | 76.5 ± 18.0 | 73.1 ± 17.5 | 0.67 |
BMI: body mass index; BSA: body surface area; CMR: cardiac magnetic resonance; LV: left ventricular. Note:
Fisher’s exact test was used to compare proportions between diastolic severity grades.
Diastolic measurements by echocardiography and cardiac magnetic resonance
| Normal n = 66 (64.70%) | Type I n = 21 (20.60%) | Type II n = 15 (14.70%) | p value | |
|---|---|---|---|---|
| E (cm/s) | 74.53 ± 16.43 | 74.89 ± 20.76 | 87.68 ± 20.94 | 0.03 |
| DT (ms) | 220.14 ± 45.19 | 247.95 ± 76.70 | 258.4 ± 77.69 | 0.03 |
| A (cm/s) | 77.66 ± 19.59 | 75.40 ± 19.55 | 77.18 ± 23.09 | 0.90 |
| E/A | 0.99 ± 0.24 | 1.02 ± 0.22 | 1.23 ± 0.47 | 0.01 |
| e’ (cm/s) | 9.38 ± 1.69 | 8.33 ± 2.12 | 6.00 ± 1.26 | <0.0001 |
| E/e’ | 8.20 ± 2.24 | 9.23 ± 2.22 | 15.37 ± 5.91 | <0.0001 |
| e’(cm/s) | 11.61 ± 2.45 | 8.23 ± 1.68 | 6.97 ± 1.80 | <0.0001 |
| E/e’ | 6.65 ± 1.82 | 9.37 ± 3.22 | 13.36 ± 5.21 | <0.0001 |
| e’ (cm/s) | 10.47 ± 1.59 | 8.27 ± 1.45 | 6.48 ± 1.44 | <0.0001 |
| E/e’ | 7.25 ± 1.78 | 9.12 ± 2.06 | 14.19 ± 5.40 | <0.0001 |
| E (mL/s) | 189.30 ± 66.39 | 206.30 ± 62.58 | 213.60 ± 71.67 | 0.33 |
| NE (s-1) | 1.77 ± 0.46 | 1.89 ± 0.50 | 2.11 ± 0.43 | 0.03 |
| DT (ms) | 186.61 ± 43.94 | 211.08 ± 43.75 | 218.37 ± 42.59 | 0.01 |
| TPE (ms) | 504.86 ± 82.41 | 493.46 ± 68.75 | 517.54 ± 37.80 | 0.63 |
| A (mL/s) | 181.13 ± 72.08 | 211.09 ± 75.17 | 164.73 ± 43.96 | 0.11 |
| NA(s-1) | 1.70 ± 0.53 | 1.98 ± 0.76 | 1.71 ± 0.58 | 0.16 |
| TPA (ms) | 837.27 ± 193.40 | 861.57 ± 155.17 | 866.00 ± 115.64 | 0.78 |
| E/A | 1.10 ± 0.38 | 1.01 ± 0.26 | 1.33 ± 0.45 | 0.03 |
| DVR (ms) | 535.32 ± 117.96 | 542.44 ± 122.45 | 516.08 ± 78.16 | 0.80 |
| E’ (mm/s) | 75.35 ± 24.49 | 66.49 ± 25.31 | 58.22 ± 24.11 | 0.03 |
| E/E’ (mL/mm) | 2.64 ± 0.96 | 3.45 ± 1.60 | 4.65 ± 3.38 | 0.0002 |
| E’ (mm/s) | 82.36 ± 26.14 | 70.88 ± 28.45 | 61.06 ± 27.73 | 0.01 |
| E/E’ (mL/mm) | 2.40 ± 0.83 | 3.32 ± 1.80 | 4.52 ± 3.54 | 0.0001 |
| E’ (mm/s) | 78.86 ± 24.85 | 68.69 ± 26.26 | 59.64 ± 25.45 | 0.02 |
| E/E’ (mL/mm) | 2.50 ± 0.87 | 3.33 ± 1.53 | 4.55 ± 3.44 | 0.0001 |
E: early peak filling rate; DT: deceleration time; A: atrial peak filling rate; E/A:E/A ratio; e’: early diastolic myocardial relaxation velocity; E/e’: E/e’ ratio; NE: normalized peak E filling rate; NA: normalized peak A filling rate; DVR: diastolic volume recovery; E’: early longitudinal relaxation rate; CMR: cardiac magnetic resonance, TPE: time to peak E; TPA: time to peak A.
Associations between measures of diastolic function by echocardiography and cardiac magnetic resonance (n = 102)
| Echocardiography | CMR | Pearson’s correlation coefficient (r) | p value |
|---|---|---|---|
| E (cm/s) | E (mL/s) | 0.06 | 0.51 |
| E (cm/s) | NE (s-1) | 0.1 | 0.18 |
| A (cm/s) | A (mL/s) | 0.22 | 0.01 |
| A (cm/s) | NA (s-1) | 0.28 | 0.003 |
| E/A | E/A | 0.71 | < 0.0001 |
| e’ (cm/s) | E’ (mm/s) | 0.11 | 0.26 |
| E/e’ | E/E’ (mL/mm) | 0.11 | 0.30 |
| e’ (cm/s) | E’ (mm/s) | 0.26 | 0.007 |
| E/e’ | E/E’ (mL/mm) | 0.24 | 0.01 |
| e’ (cm/s) | E’ (mm/s) | 0.22 | 0.02 |
| E/e’ | E/E’ (mL/mm) | 0.17 | 0.07 |
CMR: cardiac magnetic resonance; early peak filling rate; A: atrial peak filling rate; e’: early diastolic myocardial relaxation velocity; NE: normalized peak E filling rate; NA: normalized peak A filling rate; E/A: E/A ratio; E’: early longitudinal relaxation rate. Echocardiography corresponds to Doppler echocardiography.
Figure 4Results obtained using cardiac magnetic resonance (CMR) three-dimensional volume-curve and echocardiography Doppler mitral valve inflow. The ratio between the early peak filling (E) and atrial peak filling rate (A) using velocity (cm/s) by echocardiography and flow (mL/s) by CMR. (A) Linear regression and Pearson's correlation; (B) Bland-Altman analysis.
Prediction of reduced diastolic function by cardiac magnetic resonance (n = 81)
| CMR | Area under the ROC curve | p value |
|---|---|---|
| E (mL/s) | 0.60 | 0.21 |
| NE (s-1) | 0.70 | 0.008 |
| DT (ms) | 0.72 | 0.01 |
| A (mL/s) | 0.53 | 0.37 |
| NA (s-1) | 0.48 | 0.92 |
| DVR (ms) | 0.51 | 0.57 |
| E/A | 0.66 | 0.05 |
| E’ (mm/s) | 0.67 | 0.01 |
| E/E’ (mL/mm) | 0.76 | 0.0003 |
| E’ (mm/s) | 0.70 | 0.0004 |
| E/E’ (mL/mm) | 0.80 | < 0.0001 |
| E’ (mm/s) | 0.69 | 0.006 |
| E/E’ (mL/mm) | 0.78 | 0.0001 |
CMR: cardiac magnetic resonance; ROC: receiver operating characteristic; E: early peak filling rate; NE: normalized peak E filling rate; DT: deceleration time; A: atrial peak filling rate; NA: normalized peak A filling rate; DVR: diastolic volume recovery; E/A: E/A ratio; E’: early longitudinal relaxation rate; E/E’: E/E’ ratio.
Intraobserver and interobserver agreement (n = 20)
| Intraclass correlation coefficient (ICC) | Bias | 95% limits of agreement | |
|---|---|---|---|
| Mitral inflow velocities | |||
| E (cm/s) | 0.93 | -1.66 | -11.70 to 8.36 |
| DT (ms) | 0.84 | 9.84 | -38.67 to 58.36 |
| A (cm/s) | 0.95 | -1.12 | -14.84 to 12.59 |
| e’ (cm/s) | 0.85 | 0.42 | -1.84 to 2.68 |
| e’ (cm/s) | 0.89 | -0.37 | -1.76 to 2.49 |
| E (cm/s) | 0.95 | -1.39 | -9.22 to 6.44 |
| DT (ms) | 0.72 | 6.77 | -62.40 to 75.96 |
| A (cm/s) | 0.96 | -0.22 | -12.85 to 12.39 |
| e’ (cm/s) | 0.89 | 0.28 | -1.78 to 2.35 |
| e’ (cm/s) | 0.92 | -0.59 | -2.06 to 0.86 |
| E (mL/s) | 0.84 | 2.54 | -79.77 to 84.86 |
| DT (ms) | 0.77 | -21.52 | -81.75 to 38.70 |
| A (mL/s) | 0.82 | 22.89 | -51.20 to 97.00 |
| E’ (mm/s) | 0.75 | -4.90 | -32.59 to 22.63 |
| E’ (mm/s) | 0.89 | -5.48 | -25.24 to 14.27 |
| E (mL/s) | 0.97 | -1.36 | -33.73 to 31.00 |
| DT (ms) | 0.84 | 12.93 | -28.46 to 28.46 |
| A (mL/s) | 0.96 | -15.51 | -64.82 to 33.79 |
| E’ (mm/s) | 0.85 | -2.93 | -23.91 to 18.03 |
| E’ (mm/s) | 0.94 | -4.11 | -18.93 to 10.70 |
Note: R1: reader 1 and R2: reader 2. E: early peak filling rate; DT: deceleration time; A: atrial peak filling rate; e’: early diastolic myocardial relaxation velocity; E’: early longitudinal relaxation rate.